Literature DB >> 17171658

Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses.

Eva Kereszturi1, Orsolya Kiraly, Zsolt Csapo, Zsanett Tarnok, Julia Gadoros, Maria Sasvari-Szekely, Zsofia Nemoda.   

Abstract

Abnormalities of the dopamine neurotransmission have been hypothesized to play an important role in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Promoter variants of the dopamine D4 receptor gene (DRD4) have attracted particular interest due to their possible role in regulation of gene transcription. Here we describe the haplotype analysis of the 120 base pair duplication (120-bp dup) and three SNPs (-616C/G, -615A/G, -521C/T) in the 5' region of the DRD4 gene among children with ADHD. We observed a trend (chi(2) = 14.905, df = 9, P = 0.093) in the four-locus haplotype distribution between ADHD probands (N = 173) and controls (N = 284). The homozygote genotype of the 1-repeat form of the 120-bp dup (1-1) had a significantly higher frequency among ADHD children than in controls (8.1% vs. 3.2%, chi(2) = 5.526, df = 1, P = 0.019, Odds Ratio = 2.71). In addition, a novel, 4-repeat allele was identified among ADHD patients. This particular allele has been cloned to the luciferase expression vector and its transcriptional activity has been compared to the 1- and 2-repeat allele. The number of repeats of the 120-bp dup was found to have an effect on transcriptional activity in both neuroblastoma and retinoblastoma cell lines in a dose-dependent manner (1-repeat > 2-repeat > 4-repeat). These results suggest that the 1-repeat form of the 120-bp dup might be a risk factor of ADHD, especially in the homozygous form and/or in the context of certain haplotypes. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17171658     DOI: 10.1002/ajmg.b.30444

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  19 in total

1.  The dopamine receptor D4 gene (DRD4) moderates family environmental effects on ADHD.

Authors:  Michelle M Martel; Molly Nikolas; Katherine Jernigan; Karen Friderici; Irwin Waldman; Joel T Nigg
Journal:  J Abnorm Child Psychol       Date:  2011-01

2.  Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability.

Authors:  Bàrbara Torrico; Noèlia Fernàndez-Castillo; Amaia Hervás; Montserrat Milà; Marta Salgado; Isabel Rueda; Jan K Buitelaar; Nanda Rommelse; Anoek M Oerlemans; Janita Bralten; Christine M Freitag; Andreas Reif; Agatino Battaglia; Luigi Mazzone; Elena Maestrini; Bru Cormand; Claudio Toma
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 3.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

4.  The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding.

Authors:  Jared W Young; Susan B Powell; Christine N Scott; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2011-03-31       Impact factor: 3.332

Review 5.  Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood.

Authors:  Zsofia Nemoda; Anna Szekely; Maria Sasvari-Szekely
Journal:  Neurosci Biobehav Rev       Date:  2011-04-15       Impact factor: 8.989

Review 6.  ADHD genetics: 2007 update.

Authors:  Josephine Elia; Marcella Devoto
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 7.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

8.  Neuropsychological performance measures as intermediate phenotypes for attention-deficit/hyperactivity disorder: A multiple mediation analysis.

Authors:  Jaclyn M Kamradt; Joel T Nigg; Karen H Friderici; Molly A Nikolas
Journal:  Dev Psychopathol       Date:  2016-04-06

9.  Amphetamine improves mouse and human attention in the 5-choice continuous performance test.

Authors:  David A MacQueen; Arpi Minassian; Johnny A Kenton; Mark A Geyer; William Perry; Jonathan L Brigman; Jared W Young
Journal:  Neuropharmacology       Date:  2018-05-31       Impact factor: 5.250

10.  DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Authors:  Darko Turic; James Swanson; Edmund Sonuga-Barke
Journal:  Pharmgenomics Pers Med       Date:  2010-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.